Homework Help is Here – Start Your Trial Now!
Business
Accounting
For the fiscal year ended June 30, 2025, calculate the following for Windsor Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $

For the fiscal year ended June 30, 2025, calculate the following for Windsor Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $

Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
4th Edition
ISBN:9781337690881
Author:Jay Rich, Jeff Jones
Publisher:Jay Rich, Jeff Jones
Chapter10: Stockholder's Equity
Section: Chapter Questions
Problem 84PSB: Statement of Stockholders' Equity At the end of 2019, Stanley Utilities Inc. had the following...
See similar textbooks
icon
Related questions
Question
100%
Amy Dyken, controller at Windsor Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Windsor's financial statements. Below is selected financial information for the fiscal year ended June 30, 2025. Long-term debt Notes payable, 10% 9% convertible bonds payable 10% bonds payable Total long-term debt Shareholders' equity Preferred stock, 5% cumulative, $50 par value, 109,000 shares authorized, 27,250 shares issued and outstanding Common stock, $1 par, 9,800,000 shares authorized, 980,000 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity The following transactions have also occurred at Windsor. 1. 2. 3. 4. Windsor Pharmaceutical Industries Selected Balance Sheet Information June 30, 2025 5. 6. $1,000,000 5,050,000 5,920,000 $11,970,000 $1,362,500 980,000 3,930,000 6,050,000 $12,322,500 Options were granted on July 1, 2024, to purchase 220,000 shares at $14 per share. Although no options were exercised during fiscal year 2025, the average price per common share during fiscal year 2025 was $20 per share. Each bond was issued at face value. The 9% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2024. The preferred stock was issued in 2024. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2025. The 980,000 shares of common stock were outstanding for the entire 2025 fiscal year. Net income for fiscal year 2025 was $1,480,000, and the average income tax rate is 20%.
Transcribed Image Text:Amy Dyken, controller at Windsor Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Windsor's financial statements. Below is selected financial information for the fiscal year ended June 30, 2025. Long-term debt Notes payable, 10% 9% convertible bonds payable 10% bonds payable Total long-term debt Shareholders' equity Preferred stock, 5% cumulative, $50 par value, 109,000 shares authorized, 27,250 shares issued and outstanding Common stock, $1 par, 9,800,000 shares authorized, 980,000 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity The following transactions have also occurred at Windsor. 1. 2. 3. 4. Windsor Pharmaceutical Industries Selected Balance Sheet Information June 30, 2025 5. 6. $1,000,000 5,050,000 5,920,000 $11,970,000 $1,362,500 980,000 3,930,000 6,050,000 $12,322,500 Options were granted on July 1, 2024, to purchase 220,000 shares at $14 per share. Although no options were exercised during fiscal year 2025, the average price per common share during fiscal year 2025 was $20 per share. Each bond was issued at face value. The 9% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2024. The preferred stock was issued in 2024. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2025. The 980,000 shares of common stock were outstanding for the entire 2025 fiscal year. Net income for fiscal year 2025 was $1,480,000, and the average income tax rate is 20%.
For the fiscal year ended June 30, 2025, calculate the following for Windsor Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $
Transcribed Image Text:For the fiscal year ended June 30, 2025, calculate the following for Windsor Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share $ b. Diluted earnings per share. Diluted earnings per share $
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 4 steps with 4 images

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Follow-up Questions
Read through expert solutions to related follow-up questions below.
Follow-up Question

how did you calculate the net income of 1480000?

Solution
Bartleby Expert
SEE SOLUTION
Knowledge Booster
Income Statement Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
Accounting
ISBN:
9781337690881
Author:
Jay Rich, Jeff Jones
Publisher:
Cengage Learning
Intermediate Accounting: Reporting And Analysis
Intermediate Accounting: Reporting And Analysis
Accounting
ISBN:
9781337788281
Author:
James M. Wahlen, Jefferson P. Jones, Donald Pagach
Publisher:
Cengage Learning
Principles of Accounting Volume 1
Principles of Accounting Volume 1
Accounting
ISBN:
9781947172685
Author:
OpenStax
Publisher:
OpenStax College
Managerial Accounting: The Cornerstone of Busines…
Managerial Accounting: The Cornerstone of Busines…
Accounting
ISBN:
9781337115773
Author:
Maryanne M. Mowen, Don R. Hansen, Dan L. Heitger
Publisher:
Cengage Learning
Financial Accounting: The Impact on Decision Make…
Financial Accounting: The Impact on Decision Make…
Accounting
ISBN:
9781305654174
Author:
Gary A. Porter, Curtis L. Norton
Publisher:
Cengage Learning
SEE MORE TEXTBOOKS